Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Multicenter, Single-arm, Open Label Treatment Protocol to Provide Expanded Access to Enzalutamide (MDV3100) and Monitor Its Safety in Patients with Progressive Castration-Resistant Prostate Cancer Previously Treated with Docetaxel-Based Chemotherapy
enzalutamide
9785-CL-0401
NCT01606982
Castration-resistant prostate cancer
Phase 4
 
June 2017

Powered by ideaPoint, Inc.